KarLa K. Quevedo, MD

Atrial fibrillation (AF) and heart failure (HF) often coexist. The use of beta-blockers in HF patients has a class 1A recommendation in both the European and American guidelines. In current guidelines for heart failure therapy, the recommendation for beta-blockers is not restricted to patients with sinus rhythm, and includes all HF patients.

Do mandatory follow-up visits after discharging heart failure patients decrease rehospitalizations?

Have the Appropriate Use Criteria for transthoracic echocardiography achieved their goal of having a significant clinical impact on physician decision making?